Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
about
Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.Optimizing dendritic cell-based approaches for cancer immunotherapyMetronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseLow-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing TumorsComplementing the tumor-specific immunity in tumor radiotherapyNon-clinical safety evaluation of repeated intramuscular administration of the AS15 immunostimulant combined with various antigens in rabbits and cynomolgus monkeysCrucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic TherapySynergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review.Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers.Excellent response to chemotherapy post immunotherapy.Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine.Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tuEffect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
P2860
Q33793930-CDE47944-CECF-428E-A4A0-CA86B3B16B52Q34637535-3B3B1DD9-22B0-4FF3-8772-4D7C656FA940Q35201890-F70E658C-B87D-46FA-B1BA-FD37CC9A429DQ35713347-4983F2D6-CF65-400E-9744-583FD7100206Q36060333-63099004-BAB7-4210-92B3-3AE3D48D596EQ36173622-2196E928-CD10-40BA-9186-AA1FA9E70E80Q36261283-9D7028AA-5574-4FD6-B2FB-9993DA6AF98DQ36322371-F7B04222-3A18-4420-9F39-319CD061F29CQ37165969-C80857C0-7FB1-4B0B-B7C5-135098D93ECFQ37275610-B6A1C8B6-AA77-4E2A-BDD2-6A7ECBE3FB99Q37335249-42D0DB0F-C9EC-40BE-AC82-449662FA0145Q37419153-2C55A111-296E-403C-AB1A-FB8ECDADAF97Q38765125-0046759B-A1EF-4234-8CF9-DB2FD58BF605Q38940518-8ADF5185-8D4A-44AD-B0B5-AA56C0581E2AQ39086783-D0194C2F-FBF5-46DC-95AF-4A37E9AE374DQ40274361-32E3350F-F8F0-4DED-B8BC-413E8FB06132Q41620122-F0AA27AA-6643-4860-86DB-9AC41CEF5905Q47259728-FC5AFE6B-A318-4256-9D91-9D54EF2332B0Q47296148-734D2D0D-28C3-4F34-81D6-4E55FD3F5B7AQ48121626-B84C01BD-645F-4103-AD2A-DC9E8E9F8076Q55265767-7B9CD62A-0ECF-416C-AC0B-CD26AC3684C0
P2860
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
@en
type
label
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
@en
prefLabel
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
@en
P2860
P356
P1433
P1476
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
@en
P2093
Marc Mansour
Robert S Liwski
P2860
P304
P356
10.3390/CANCERS3033114
P577
2011-08-05T00:00:00Z